Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 74401 - 74425 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Simvastatin	Approved Investigational	TNFRSF4	7293	downregulated	Simvastatin results in decreased expression of TNFRSF4 mRNA	1p36.33	A24288
Simvastatin	Approved Investigational	TNFSF4	7292	downregulated	Simvastatin results in decreased expression of TNFSF4 mRNA	1q25.1	A24288
Simvastatin	Approved Investigational	TP53	7157	upregulated	Simvastatin results in increased expression of TP53 mRNA	17p13.1	A23128
Simvastatin	Approved Investigational	TRA	6955	downregulated	Simvastatin results in decreased expression of TRA mRNA	14q11.2	A24148
Simvastatin	Approved Investigational	TRADD	8717	downregulated	Simvastatin results in decreased expression of TRADD mRNA	16q22.1	A24275
Simvastatin	Approved Investigational	TRAF2	7186	downregulated	Simvastatin results in decreased expression of TRAF2 mRNA	9q34.3	A24275
Simvastatin	Approved Investigational	TYMS	7298	downregulated	Simvastatin results in decreased expression of TYMS mRNA	18p11.32	A24239
Simvastatin	Approved Investigational	VCAM1	7412	downregulated	Simvastatin results in decreased expression of VCAM1 mRNA	1p21.2	A20980
Simvastatin	Approved Investigational	VEGFA	7422	upregulated	Simvastatin results in increased expression of VEGFA mRNA	6p21.1	A24289
Sirolimus	Approved Investigational	ABCA1	19	upregulated	Sirolimus results in increased expression of ABCA1 mRNA	9q31.1	A24290
Sirolimus	Approved Investigational	BCL2	596	downregulated	Sirolimus results in decreased expression of BCL2 mRNA	18q21.33	A22649
Sirolimus	Approved Investigational	CASP3	836	upregulated	Sirolimus results in increased expression of CASP3 mRNA	4q35.1	A22649
Sirolimus	Approved Investigational	CCND3	896	downregulated	Sirolimus results in decreased expression of CCND3 mRNA	6p21.1	A24291
Sirolimus	Approved Investigational	CCNG2	901	upregulated	Sirolimus results in increased expression of CCNG2 mRNA	4q21.1	A20727
Sirolimus	Approved Investigational	CD68	968	downregulated	Sirolimus results in decreased expression of CD68 mRNA	17p13.1	A24290
Sirolimus	Approved Investigational	CD84	8832	upregulated	Sirolimus results in increased expression of CD84 mRNA	1q23.3	A20727
Sirolimus	Approved Investigational	CDKN1A	1026	upregulated	Sirolimus results in increased expression of CDKN1A mRNA	6p21.2	A22649 A24292
Sirolimus	Approved Investigational	CYP2B6	1555	upregulated	Sirolimus results in increased expression of CYP2B6 mRNA	19q13.2	A22538
Sirolimus	Approved Investigational	CYP2C9	1559	upregulated	Sirolimus results in increased expression of CYP2C9 mRNA	10q23.33	A22538
Sirolimus	Approved Investigational	DPYD	1806	downregulated	Sirolimus results in decreased expression of DPYD mRNA	1p21.3	A22649
Sirolimus	Approved Investigational	DUSP10	11221	upregulated	Sirolimus results in increased expression of DUSP10 mRNA	1q41	A20727
Sirolimus	Approved Investigational	EVI2A	2123	upregulated	Sirolimus results in increased expression of EVI2A mRNA	17q11.2	A20727
Sirolimus	Approved Investigational	FBXO32	114907	upregulated	Sirolimus results in increased expression of FBXO32 mRNA	8q24.13	A20727
Sirolimus	Approved Investigational	FRAT1	10023	upregulated	Sirolimus results in increased expression of FRAT1 mRNA	10q24.1	A20727
Sirolimus	Approved Investigational	GPR18	2841	upregulated	Sirolimus results in increased expression of GPR18 mRNA	13q32.3	A20727

Displaying entries 74401 - 74425 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability